Skip to main content
Equibles
PRCT logo

PRCT · PROCEPT BioRobotics Corp · Earnings Call Transcripts & Audio

Track PRCT — free

Use PRCT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PRCT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$18.22 +0.00 (+0.00%) At close · Sep 30
Russell 2000 member Rebalance outlook locked
Market Cap
$985.11M
Shares
57.27M
Volume · Sep 30 1.59M Avg daily vol (3M) 1.47M

PROCEPT BioRobotics Corp Earnings Call Transcripts

Quarterly earnings calls for PROCEPT BioRobotics Corp (PRCT), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲134.8% $20.35M −$22.61M '22 Q3 22-11-03 ▲134.6% $23.78M −$28.17M '22 Q4 23-02-28 ▲71.9% $24.40M −$28.48M '23 Q1 23-04-27 ▲98.3% $33.10M −$25.29M '23 Q2 23-07-27 ▲72.5% $35.10M −$24.62M '23 Q3 23-11-01 ▲83.3% $43.58M −$27.51M '23 Q4 24-02-27 ▲82.5% $44.54M −$25.96M '24 Q1 24-05-01 ▲61.2% $53.35M −$25.63M '24 Q2 24-08-01 ▲66.3% $58.37M −$20.97M '24 Q3 24-10-28 ▲56.6% $68.24M −$18.86M '24 Q4 25-02-25 ▲55.3% $69.16M −$24.74M '25 Q1 25-04-24 ▲48.4% $79.18M −$19.58M '25 Q2 25-08-06 ▲42.8% $83.33M −$21.41M '25 Q3 25-11-04 ▲11.9% $76.38M −$29.85M '25 Q4 26-02-25 ▲20.2% $83.13M −$31.64M '26 Q1 26-04-29 LATEST ▲19.3% $94.50M −$26.86M '26 Q2 26-08-04
Earnings call
FY26 · Q2
2026-08-04
PROCEPT BioRobotics Corp (PRCT) Q2 2026 Earnings Call Transcript
Positive tone Procedure growth shortfall in legacy AquaBeam accounts Guidance and path to profitability Hydros robotic system rollout
Revenue
$94.50M
▲ 19.3% YoY
Diluted EPS
$-0.47
Gross margin
66.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-02
PROCEPT BioRobotics Corp (PRCT) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-04-29
PROCEPT BioRobotics Corp (PRCT) Q1 2026 Earnings Call Transcript
Confident tone Revenue and procedure growth Pricing discipline and ASP Commercial realignment and launch team
Revenue
$83.13M
▲ 20.2% YoY
Diluted EPS
$-0.56
Gross margin
64.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-25
PROCEPT BioRobotics Corp (PRCT) Q4 2025 Earnings Call Transcript
Positive tone Capital system placements Procedure growth and utilization Profitability path and operating expenses
Revenue
$76.38M*
▲ 11.9% YoY
Gross margin
60.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
PROCEPT BioRobotics Corp (PRCT) Q3 2025 Earnings Call Transcript
Positive tone Procedure utilization / new account launches U.S. capital systems / HYDROS placements BPH market opportunity / therapy awareness
Revenue
$83.33M
▲ 42.8% YoY
Diluted EPS
$-0.38
Gross margin
64.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
PROCEPT BioRobotics Corp (PRCT) Q2 2025 Earnings Call Transcript
Confident tone HYDROS platform launch Gross margin and path to profitability WATER IV trial and prostate cancer
Revenue
$79.18M
▲ 48.4% YoY
Diluted EPS
$-0.35
Gross margin
65.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-24
PROCEPT BioRobotics Corp (PRCT) Q1 2025 Earnings Call Transcript
Confident tone Commercial execution and account launches Revenue and unit growth Capital equipment sales cycle and pipeline
Revenue
$69.16M
▲ 55.3% YoY
Diluted EPS
$-0.45
Gross margin
63.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
PROCEPT BioRobotics Corp (PRCT) Q4 2024 Earnings Call Transcript
Confident tone HYDROS Robotic System Launch BPH Market Share and Standard of Care Revenue Growth and Procedures
Revenue
$68.24M*
▲ 56.6% YoY
Gross margin
64.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-28
PROCEPT BioRobotics Corp (PRCT) Q3 2024 Earnings Call Transcript
Confident tone HYDROS Robotic System Launch Prostate Cancer Clinical Study / WATER IV PCa Q4 2024 Guidance and System Sales Outlook
Revenue
$58.37M
▲ 66.3% YoY
Diluted EPS
$-0.40
Gross margin
63.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
PROCEPT BioRobotics Corp (PRCT) Q2 2024 Earnings Call Transcript
Confident tone Revenue growth and U.S. system sales Prostate cancer expansion and clinical studies Gross margin and operating leverage
Revenue
$53.35M
▲ 61.2% YoY
Diluted EPS
$-0.50
Gross margin
59.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
PROCEPT BioRobotics Corp (PRCT) Q1 2024 Earnings Call Transcript
Confident tone Revenue Growth and Financial Performance U.S. Installed Base and Hospital Adoption Prostate Cancer Opportunity and AUA Conference
Revenue
$44.54M
▲ 82.5% YoY
Diluted EPS
$-0.51
Gross margin
56.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
PROCEPT BioRobotics Corp (PRCT) Q4 2023 Earnings Call Transcript
Confident tone Revenue Growth and Utilization BPH Standard of Care Strategy IDN and Reimbursement
Revenue
$43.58M*
▲ 83.3% YoY
Gross margin
48.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-01
PROCEPT BioRobotics Corp (PRCT) Q3 2023 Earnings Call Transcript
Revenue
$35.10M
▲ 72.5% YoY
Diluted EPS
$-0.51
Gross margin
53.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-07-27
PROCEPT BioRobotics Corp (PRCT) Q2 2023 Earnings Call Transcript
Revenue
$33.10M
▲ 98.3% YoY
Diluted EPS
$-0.56
Gross margin
55.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-04-27
PROCEPT BioRobotics Corp (PRCT) Q1 2023 Earnings Call Transcript
Revenue
$24.40M
▲ 71.9% YoY
Diluted EPS
$-0.63
Gross margin
51.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
PROCEPT BioRobotics Corp (PRCT) Q4 2022 Earnings Call Transcript
Revenue
$23.78M*
▲ 134.6% YoY
Gross margin
44.9%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
PROCEPT BioRobotics Corp (PRCT) Q3 2022 Earnings Call Transcript
Revenue
$20.35M
▲ 134.8% YoY
Diluted EPS
$-0.51
Gross margin
50.3%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
PROCEPT BioRobotics Corp (PRCT) Q2 2022 Earnings Call Transcript
Revenue
$16.69M
▲ 96.9% YoY
Diluted EPS
$-0.43
Gross margin
50.8%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
PROCEPT BioRobotics Corp (PRCT) Q1 2022 Earnings Call Transcript
Revenue
$14.20M
▲ 97.4% YoY
Diluted EPS
$-0.39
Gross margin
54.2%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-01-11
PROCEPT BioRobotics Corp (PRCT) Q4 2021 Earnings Call Transcript
Revenue
$10.14M*
Gross margin
44.5%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
PROCEPT BioRobotics Corp (PRCT) Q3 2021 Earnings Call Transcript
Revenue
$8.67M
▲ 311.4% YoY
Diluted EPS
$-1.22
Gross margin
48.9%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–21 of 21 earnings calls
Key facts CIK 1588978 CUSIP 74276L105 13F (30d) 5 filings 5 filers Visit website Investor relations